Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations.
Athyrium has over $600 million under management.
Madison Dearborn Partners to Acquire Ikaria
Pernix Attracts $65 Million Institutional Investment
Universal Biosensors Secures up to $25 Million Loan Facility
Total Artificial Heart Manufacturer SynCardia Secures $14 Million in Growth Financing
Horizon Pharma Announces Pricing of $150 Million of 5.00% Convertible Senior Notes
InnoPharma Inc. Completes $20 Million Term Loan Facility
Verenium Enters Agreement to be Acquired by BASF
bioMerieux to Acquire BioFire Diagnostics for $450 Million Plus Net Financial Debt
Athyrium is a specialized asset management company with over $600 million under management. Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations....
Limited Partnership Interests
Sign up for updates and news from Athyrium Capital Management. Your email will not be distributed or used for any third party purposes.